Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Nov 1.

Published in final edited form as: Am J Med. 2021 Jul 31;134(11):1321–1329. doi: 10.1016/j.amjmed.2021.06.038

Figure 3: — (A) Flow diagram summarizing the management algorithm for MINOCA patients; (B) Flow diagram summarizing the management algorithm for INOCA/ANOCA patients. ACEI = angiotensin-converting enzyme inhibitor; ANOCA = angina pectoris highly suspect for but without ischemia or biomarker positivity in nonobstructive coronary arteries; BB = beta blocker; CCB = calcium channel blocker; CMD = coronary microvascular dysfunction; INOCA = ischemia without elevated biomarkers of cardiomyocyte injury in patients with nonobstructive coronary arteries; MINOCA = myocardial infarction with nonobstructive coronary arteries.

Figure 3: — (A) Flow diagram summarizing the management algorithm for MINOCA patients; (B) Flow diagram summarizing the management algorithm for INOCA/ANOCA patients. ACEI = angiotensin-converting enzyme inhibitor; ANOCA = angina pectoris highly suspect for but without ischemia or biomarker positivity in nonobstructive coronary arteries; BB = beta blocker; CCB = calcium channel blocker; CMD = coronary microvascular dysfunction; INOCA = ischemia without elevated biomarkers of cardiomyocyte injury in patients with nonobstructive coronary arteries; MINOCA = myocardial infarction with nonobstructive coronary arteries.